StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Monday. The brokerage set a “buy” rating on the stock.

Mannatech Price Performance

Shares of NASDAQ MTEX opened at $8.05 on Monday. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The stock has a market capitalization of $15.13 million, a P/E ratio of -9.94 and a beta of 1.17. The company’s 50-day moving average is $7.78 and its 200 day moving average is $7.54. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million for the quarter.

Insider Buying and Selling at Mannatech

In related news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now owns 54,721 shares in the company, valued at $424,087.75. This represents a 22.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.